Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-12

AUTHORS

Per-Göran Larsson, Babill Stray-Pedersen, Kjeld R Ryttig, Stig Larsen

ABSTRACT

BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834. More... »

PAGES

3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6874-8-3

DOI

http://dx.doi.org/10.1186/1472-6874-8-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005792714

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18197974


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravaginal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clindamycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Confidence Intervals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactobacillus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norway", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probiotics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Secondary Prevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vagina", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginosis, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Women's Health", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, K\u00e4rnsjukhuset, SE-541 85, Sk\u00f6vde, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsson", 
        "givenName": "Per-G\u00f6ran", 
        "id": "sg:person.012634564012.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stray-Pedersen", 
        "givenName": "Babill", 
        "id": "sg:person.0631122174.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Farmaservice, DK-2990, Niv\u00e5, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryttig", 
        "givenName": "Kjeld R", 
        "id": "sg:person.010725643124.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian University of Life Sciences", 
          "id": "https://www.grid.ac/institutes/grid.19477.3c", 
          "name": [
            "Norwegian School of Veterinary Science, also Ullev\u00e5l University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsen", 
        "givenName": "Stig", 
        "id": "sg:person.013272512512.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ajog.2005.11.041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003579888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007778437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(83)91112-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008512415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_01.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029477183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1471-0528.2006.00946.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032365488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/503780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034159474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-8244(02)00465-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038163667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jcm.40.8.2746-2749.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046109635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.micinf.2006.01.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049637601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00015550410022249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058255052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074813072", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076994697", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077230119", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077315051", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078295192", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-12", 
    "datePublishedReg": "2008-12-01", 
    "description": "BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure.\nMETHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial.\nRESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding \"Time from cure to relapse\" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05)\nCONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up.\nTRIAL REGISTRATION NUMBER: ISRCTN62879834.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1472-6874-8-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028438", 
        "issn": [
          "1472-6874"
        ], 
        "name": "BMC Women's Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study", 
    "pagination": "3", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18197974"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088690"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6874-8-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005792714"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6874-8-3", 
      "https://app.dimensions.ai/details/publication/pub.1005792714"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1472-6874-8-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      21 PREDICATES      69 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6874-8-3 schema:about N189be119b1204b9da739067cd9ef05fa
2 N19d03d51ac7a4d9db0d187a745f3e385
3 N2b8c4964c8c54786862c3309151be952
4 N3e50170603e446269faf034434cddb78
5 N44b1043a19c94640912efe6623d02b38
6 N46c3f050adf640d9bf01149342a370be
7 N4b2118f4928944a2913fcca19ad42fe8
8 N53fd1f0ada444ea38c5d4d4724ccb8f1
9 N5f84f67b22b44db3b8906be5f1ca3abb
10 N769201b11f55429baae310232d19bb24
11 N7ca9b1f49fca436cb1a5ff08c6f29faf
12 N8a2ab10546af44a1bf028f0fca327b46
13 N8e32fd5d2dbb464cb6c97ca01db6d441
14 N8e5a18d8ee704e14b09543ba24c0be24
15 Na3362819b4154c09a4194d8f366b8791
16 Nbb48035ca1d643ec815594ded9ba379f
17 Nc5742a68091645eda04ec63446bf6586
18 Ne87a446bb3564680bef2053c015e956d
19 Nf3f6ca0588af43e08e971993da1ffa67
20 Nfc3d0264f68b4d7a82a1d686d711fd2b
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author Nadfe7bbf8e584e17a6631f4aa74dcc9b
24 schema:citation https://app.dimensions.ai/details/publication/pub.1074813072
25 https://app.dimensions.ai/details/publication/pub.1076994697
26 https://app.dimensions.ai/details/publication/pub.1077230119
27 https://app.dimensions.ai/details/publication/pub.1077315051
28 https://app.dimensions.ai/details/publication/pub.1078295192
29 https://doi.org/10.1016/0002-9343(83)91112-9
30 https://doi.org/10.1016/j.ajog.2005.11.041
31 https://doi.org/10.1016/j.micinf.2006.01.003
32 https://doi.org/10.1016/s0928-8244(02)00465-0
33 https://doi.org/10.1080/00015550410022249
34 https://doi.org/10.1086/503780
35 https://doi.org/10.1097/00007435-199205000-00007
36 https://doi.org/10.1111/j.1471-0528.2006.00946.x
37 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x
38 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x
39 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x
40 https://doi.org/10.1128/jcm.40.8.2746-2749.2002
41 https://doi.org/10.1136/bmj.308.6924.295
42 https://doi.org/10.1136/sti.2003.006106
43 https://doi.org/10.1136/sti.78.6.413
44 schema:datePublished 2008-12
45 schema:datePublishedReg 2008-12-01
46 schema:description BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N1a45fdc1809b4d2cb9d25cf9a1ba0bb1
51 Nf0756e493e6f4f45976afb72dab94dfd
52 sg:journal.1028438
53 schema:name Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
54 schema:pagination 3
55 schema:productId N31f4499b87124ab19b40e5fa89fe7dac
56 N652d0a723dba4798b4f140934a0ed712
57 N6cac06bb8fa54523a0de1e8a7ed2b44e
58 N7ef06ce6a9e941a28728b926207620ce
59 Nd050c4d89dac40e6a920166e075596c7
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005792714
61 https://doi.org/10.1186/1472-6874-8-3
62 schema:sdDatePublished 2019-04-10T19:08
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher Nd1df22f54cad4aa99f8f7d50a7fdf88b
65 schema:url http://link.springer.com/10.1186%2F1472-6874-8-3
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N189be119b1204b9da739067cd9ef05fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Women's Health
71 rdf:type schema:DefinedTerm
72 N19d03d51ac7a4d9db0d187a745f3e385 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Norway
74 rdf:type schema:DefinedTerm
75 N1a45fdc1809b4d2cb9d25cf9a1ba0bb1 schema:volumeNumber 8
76 rdf:type schema:PublicationVolume
77 N1a8c8fc8a28b4863b4c4fdfc79007eec rdf:first sg:person.013272512512.34
78 rdf:rest rdf:nil
79 N2b8c4964c8c54786862c3309151be952 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Secondary Prevention
81 rdf:type schema:DefinedTerm
82 N31f4499b87124ab19b40e5fa89fe7dac schema:name nlm_unique_id
83 schema:value 101088690
84 rdf:type schema:PropertyValue
85 N3e50170603e446269faf034434cddb78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Combined Modality Therapy
87 rdf:type schema:DefinedTerm
88 N44b1043a19c94640912efe6623d02b38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Middle Aged
90 rdf:type schema:DefinedTerm
91 N46c3f050adf640d9bf01149342a370be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Vaginosis, Bacterial
93 rdf:type schema:DefinedTerm
94 N4b2118f4928944a2913fcca19ad42fe8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Double-Blind Method
96 rdf:type schema:DefinedTerm
97 N53fd1f0ada444ea38c5d4d4724ccb8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Vagina
99 rdf:type schema:DefinedTerm
100 N5f84f67b22b44db3b8906be5f1ca3abb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Clindamycin
102 rdf:type schema:DefinedTerm
103 N652d0a723dba4798b4f140934a0ed712 schema:name pubmed_id
104 schema:value 18197974
105 rdf:type schema:PropertyValue
106 N6cac06bb8fa54523a0de1e8a7ed2b44e schema:name doi
107 schema:value 10.1186/1472-6874-8-3
108 rdf:type schema:PropertyValue
109 N75b3edd1bd05434995d91e2b07b43c81 rdf:first sg:person.010725643124.05
110 rdf:rest N1a8c8fc8a28b4863b4c4fdfc79007eec
111 N769201b11f55429baae310232d19bb24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Humans
113 rdf:type schema:DefinedTerm
114 N7ca9b1f49fca436cb1a5ff08c6f29faf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Lactobacillus
116 rdf:type schema:DefinedTerm
117 N7d592a0e976146e5a32fd8c211074505 rdf:first sg:person.0631122174.01
118 rdf:rest N75b3edd1bd05434995d91e2b07b43c81
119 N7ee0fa8343b1440fa2cad417eb5bce40 schema:name Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway
120 rdf:type schema:Organization
121 N7ef06ce6a9e941a28728b926207620ce schema:name readcube_id
122 schema:value 1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e
123 rdf:type schema:PropertyValue
124 N8a2ab10546af44a1bf028f0fca327b46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Probiotics
126 rdf:type schema:DefinedTerm
127 N8e32fd5d2dbb464cb6c97ca01db6d441 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adult
129 rdf:type schema:DefinedTerm
130 N8e5a18d8ee704e14b09543ba24c0be24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Anti-Bacterial Agents
132 rdf:type schema:DefinedTerm
133 Na3362819b4154c09a4194d8f366b8791 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Female
135 rdf:type schema:DefinedTerm
136 Nadfe7bbf8e584e17a6631f4aa74dcc9b rdf:first sg:person.012634564012.84
137 rdf:rest N7d592a0e976146e5a32fd8c211074505
138 Nbb48035ca1d643ec815594ded9ba379f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Confidence Intervals
140 rdf:type schema:DefinedTerm
141 Nc5742a68091645eda04ec63446bf6586 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Administration, Oral
143 rdf:type schema:DefinedTerm
144 Nd050c4d89dac40e6a920166e075596c7 schema:name dimensions_id
145 schema:value pub.1005792714
146 rdf:type schema:PropertyValue
147 Nd1df22f54cad4aa99f8f7d50a7fdf88b schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 Ne1a30d483aa44ee2963bdb377deb47b2 schema:name Farmaservice, DK-2990, Nivå, Denmark
150 rdf:type schema:Organization
151 Ne5bcc5b6e3e74fb9b5c72fe27bb5c067 schema:name Department of Obstetrics and Gynaecology, Kärnsjukhuset, SE-541 85, Skövde, Sweden
152 rdf:type schema:Organization
153 Ne87a446bb3564680bef2053c015e956d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Administration, Intravaginal
155 rdf:type schema:DefinedTerm
156 Nf0756e493e6f4f45976afb72dab94dfd schema:issueNumber 1
157 rdf:type schema:PublicationIssue
158 Nf3f6ca0588af43e08e971993da1ffa67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Odds Ratio
160 rdf:type schema:DefinedTerm
161 Nfc3d0264f68b4d7a82a1d686d711fd2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Follow-Up Studies
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
168 schema:name Clinical Sciences
169 rdf:type schema:DefinedTerm
170 sg:journal.1028438 schema:issn 1472-6874
171 schema:name BMC Women's Health
172 rdf:type schema:Periodical
173 sg:person.010725643124.05 schema:affiliation Ne1a30d483aa44ee2963bdb377deb47b2
174 schema:familyName Ryttig
175 schema:givenName Kjeld R
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05
177 rdf:type schema:Person
178 sg:person.012634564012.84 schema:affiliation Ne5bcc5b6e3e74fb9b5c72fe27bb5c067
179 schema:familyName Larsson
180 schema:givenName Per-Göran
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84
182 rdf:type schema:Person
183 sg:person.013272512512.34 schema:affiliation https://www.grid.ac/institutes/grid.19477.3c
184 schema:familyName Larsen
185 schema:givenName Stig
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34
187 rdf:type schema:Person
188 sg:person.0631122174.01 schema:affiliation N7ee0fa8343b1440fa2cad417eb5bce40
189 schema:familyName Stray-Pedersen
190 schema:givenName Babill
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01
192 rdf:type schema:Person
193 https://app.dimensions.ai/details/publication/pub.1074813072 schema:CreativeWork
194 https://app.dimensions.ai/details/publication/pub.1076994697 schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1077230119 schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1077315051 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1078295192 schema:CreativeWork
198 https://doi.org/10.1016/0002-9343(83)91112-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008512415
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.ajog.2005.11.041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003579888
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.micinf.2006.01.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049637601
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0928-8244(02)00465-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163667
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1080/00015550410022249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058255052
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1086/503780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034159474
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1097/00007435-199205000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037521551
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1471-0528.2006.00946.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032365488
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007778437
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029477183
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005630776
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1128/jcm.40.8.2746-2749.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046109635
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1136/bmj.308.6924.295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062767566
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1136/sti.2003.006106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023980654
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/sti.78.6.413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019639706
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.19477.3c schema:alternateName Norwegian University of Life Sciences
229 schema:name Norwegian School of Veterinary Science, also Ullevål University Hospital, Oslo, Norway
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...